Immunoregulatory potential of pregnancy-specific β1-glycoprotein

The embryo, being half an antigenically “foreign” organism, should elicit a maternal immune response. During evolution, however, the mechanisms ensuring successful development of pregnancy have been formed. In particular, among factors providing immune tolerance during pregnancy are some proteins as...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: V. P. Timganova, M. S. Bochkova, M. B. Rayev, P. V. Khramtsov, S. A. Zamorina
Formato: article
Lenguaje:RU
Publicado: SPb RAACI 2021
Materias:
Acceso en línea:https://doaj.org/article/5b885e51e136486ebd4ea066593aa677
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:5b885e51e136486ebd4ea066593aa677
record_format dspace
spelling oai:doaj.org-article:5b885e51e136486ebd4ea066593aa6772021-11-18T08:03:51ZImmunoregulatory potential of pregnancy-specific β1-glycoprotein1563-06252313-741X10.15789/1563-0625-IPO-2170https://doaj.org/article/5b885e51e136486ebd4ea066593aa6772021-06-01T00:00:00Zhttps://www.mimmun.ru/mimmun/article/view/2170https://doaj.org/toc/1563-0625https://doaj.org/toc/2313-741XThe embryo, being half an antigenically “foreign” organism, should elicit a maternal immune response. During evolution, however, the mechanisms ensuring successful development of pregnancy have been formed. In particular, among factors providing immune tolerance during pregnancy are some proteins associated with pregnancy. The pregnancy-specific β 1-glycoprotein (PSG, PSG1; SP1; PSβG1) is a dominant fetoplacental protein produced by cyto- and syncytiotrophoblast cells, and it exhibits immunosuppressive properties. Our team of authors possesses a patented method for obtaining native human PSG preparation from blood serum of pregnant women, a mixture of PSG1, PSG3, PSG7, PSG9, and their isoforms and precursors. This review presents an analysis of our results for the period from 2015 to 2020. We studied the immunoregu-latory effects of the obtained PSG preparation at concentrations comparable to those observed in pregnancy (1, 10, 100 |ag/mL). The study was performed with peripheral blood cells obtained from non-pregnant women. It was found that PSG significantly increased the percentage of adaptive Tregs in vitro, as well as expression of CTLA-4, GITR, and production of IL-10 by these cells. It has been shown that PSG has a stimulating effect upon indoleamine-2,3-dioxygenase (IDO) activity of peripheral blood monocytes. For Th17 cells, we have demonstrated that PSG can suppress differentiation and proliferation of these cells, along with reduced production of critical proinflammatory cytokines (IL-8, IL-10, IL-17, IFNγ, MCP-1, TNF α). As for the memory T cells, PSG suppressed CD25 expression and IL-2 production by them, along with simultaneous decreased expression of Gfi1, hnRNPLL genes, thus preventing the formation of the “mature” CD45R0 isoform. PSG has been shown to inhibit naive T cells’ conversion to the terminally differentiated effector subpopulation of helper T cells. When analyzing PSG effects upon cytokine profile of immunocompetent cells, it was found that the protein predominantly suppresses the Th1 cytokine production by the studied cell types, and regulates the Th2 cytokine production in divergent manner. The results obtained are consistent with general concept of immunosuppression during pregnancy. Thus, PSG could be one of the factors preventing formation and implementation of immune response to placental antigens.V. P. TimganovaM. S. BochkovaM. B. RayevP. V. KhramtsovS. A. ZamorinaSPb RAACIarticlepregnancy-specific β 1-glycoproteinimmunomodulatory effectsimmunocompetent cellsfetomaternal immune toleranceImmunologic diseases. AllergyRC581-607RUMedicinskaâ Immunologiâ, Vol 23, Iss 3, Pp 455-468 (2021)
institution DOAJ
collection DOAJ
language RU
topic pregnancy-specific β 1-glycoprotein
immunomodulatory effects
immunocompetent cells
fetomaternal immune tolerance
Immunologic diseases. Allergy
RC581-607
spellingShingle pregnancy-specific β 1-glycoprotein
immunomodulatory effects
immunocompetent cells
fetomaternal immune tolerance
Immunologic diseases. Allergy
RC581-607
V. P. Timganova
M. S. Bochkova
M. B. Rayev
P. V. Khramtsov
S. A. Zamorina
Immunoregulatory potential of pregnancy-specific β1-glycoprotein
description The embryo, being half an antigenically “foreign” organism, should elicit a maternal immune response. During evolution, however, the mechanisms ensuring successful development of pregnancy have been formed. In particular, among factors providing immune tolerance during pregnancy are some proteins associated with pregnancy. The pregnancy-specific β 1-glycoprotein (PSG, PSG1; SP1; PSβG1) is a dominant fetoplacental protein produced by cyto- and syncytiotrophoblast cells, and it exhibits immunosuppressive properties. Our team of authors possesses a patented method for obtaining native human PSG preparation from blood serum of pregnant women, a mixture of PSG1, PSG3, PSG7, PSG9, and their isoforms and precursors. This review presents an analysis of our results for the period from 2015 to 2020. We studied the immunoregu-latory effects of the obtained PSG preparation at concentrations comparable to those observed in pregnancy (1, 10, 100 |ag/mL). The study was performed with peripheral blood cells obtained from non-pregnant women. It was found that PSG significantly increased the percentage of adaptive Tregs in vitro, as well as expression of CTLA-4, GITR, and production of IL-10 by these cells. It has been shown that PSG has a stimulating effect upon indoleamine-2,3-dioxygenase (IDO) activity of peripheral blood monocytes. For Th17 cells, we have demonstrated that PSG can suppress differentiation and proliferation of these cells, along with reduced production of critical proinflammatory cytokines (IL-8, IL-10, IL-17, IFNγ, MCP-1, TNF α). As for the memory T cells, PSG suppressed CD25 expression and IL-2 production by them, along with simultaneous decreased expression of Gfi1, hnRNPLL genes, thus preventing the formation of the “mature” CD45R0 isoform. PSG has been shown to inhibit naive T cells’ conversion to the terminally differentiated effector subpopulation of helper T cells. When analyzing PSG effects upon cytokine profile of immunocompetent cells, it was found that the protein predominantly suppresses the Th1 cytokine production by the studied cell types, and regulates the Th2 cytokine production in divergent manner. The results obtained are consistent with general concept of immunosuppression during pregnancy. Thus, PSG could be one of the factors preventing formation and implementation of immune response to placental antigens.
format article
author V. P. Timganova
M. S. Bochkova
M. B. Rayev
P. V. Khramtsov
S. A. Zamorina
author_facet V. P. Timganova
M. S. Bochkova
M. B. Rayev
P. V. Khramtsov
S. A. Zamorina
author_sort V. P. Timganova
title Immunoregulatory potential of pregnancy-specific β1-glycoprotein
title_short Immunoregulatory potential of pregnancy-specific β1-glycoprotein
title_full Immunoregulatory potential of pregnancy-specific β1-glycoprotein
title_fullStr Immunoregulatory potential of pregnancy-specific β1-glycoprotein
title_full_unstemmed Immunoregulatory potential of pregnancy-specific β1-glycoprotein
title_sort immunoregulatory potential of pregnancy-specific β1-glycoprotein
publisher SPb RAACI
publishDate 2021
url https://doaj.org/article/5b885e51e136486ebd4ea066593aa677
work_keys_str_mv AT vptimganova immunoregulatorypotentialofpregnancyspecificb1glycoprotein
AT msbochkova immunoregulatorypotentialofpregnancyspecificb1glycoprotein
AT mbrayev immunoregulatorypotentialofpregnancyspecificb1glycoprotein
AT pvkhramtsov immunoregulatorypotentialofpregnancyspecificb1glycoprotein
AT sazamorina immunoregulatorypotentialofpregnancyspecificb1glycoprotein
_version_ 1718422287359672320